Last updated: 2020-12-24

0.1 Introduction

Drug Classification Challenges:

  • Clinically relevant classification for data collection and analysis purposes
  • Interoperability across consortia, including ASCO

0.2 Reingold-Tilford Tree Diagrams

0.2.1 Antibody Drug Conjugates

0.2.1.1 Without Siblings

collapsibleTree

0.2.1.2 With Siblings

collapsibleTree

0.2.2 Cellular Therapy

0.2.2.1 Without Siblings

collapsibleTree

0.2.2.2 With Siblings

collapsibleTree

0.2.3 Checkpoint Inhibitors

0.2.3.1 Without Siblings

collapsibleTree

0.2.3.2 With Siblings

collapsibleTree

0.2.4 Cytotoxic Chemotherapy

0.2.4.1 Without Siblings

collapsibleTree

0.2.4.2 With Siblings

collapsibleTree

0.2.5 Endocrine Therapy

0.2.5.1 Without Siblings

collapsibleTree

0.2.5.2 With Siblings

collapsibleTree

0.2.6 Immunomodulators and Immunostimulants

0.2.6.1 Without Siblings

collapsibleTree

0.2.6.2 With Siblings

collapsibleTree

0.2.7 Intravesicular Therapy

0.2.7.1 Without Siblings

collapsibleTree

0.2.7.2 With Siblings

collapsibleTree

0.2.8 Monoclonal Antibody Targeted Therapy

0.2.8.1 Without Siblings

collapsibleTree

0.2.8.2 With Siblings

collapsibleTree

0.2.9 Other Immunotherapy

0.2.9.1 Without Siblings

collapsibleTree

0.2.9.2 With Siblings

collapsibleTree